Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

ClinicalTrials.gov ID: NCT04273945

Public ClinicalTrials.gov record NCT04273945. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

Study identification

NCT ID
NCT04273945
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actelion
Industry
Enrollment
935 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2020 (Actual)
Primary completion
Oct 7, 2025 (Actual)
Completion
Feb 20, 2029 (Estimated)
Last update posted
Oct 6, 2026

2020 – 2029

United States locations

U.S. sites
43
U.S. states
24
U.S. cities
38
Facility City State ZIP Site status
Mayo Clinic Phoenix Arizona 85054 —
Arizona Pulmonary Specialists, Ltd Scottsdale Arizona 85258 —
Scripps Memorial Hospital La Jolla California 92037 —
USC Keck Los Angeles California 90033 —
Jeffrey S. Sager, MD Medical Corporation Santa Barbara California 93105 —
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502-2006 —
National Jewish Health Denver Colorado 80206 —
Cleveland Clinic Weston Florida 33331 3609 —
Piedmont Healthcare Atlanta Georgia 30309 —
Northside Hospital Atlanta Georgia 30342 —
Advocate Christ Medical Center Oak Lawn Illinois 60453 —
Indiana University Indianapolis Indiana 46202 —
St. Vincent Medical Group, Inc. Indianapolis Indiana 46260 —
University Of Iowa - Hospitals & Clinics Iowa City Iowa 52242 —
Norton Pulmonary Specialists Louisville Kentucky 40202 —
Louisiana State University New Orleans Louisiana 70112 7021 —
University of Michigan Ann Arbor Michigan 48109-5000 —
Troy Beaumont Troy Michigan 53215 —
Washington University School Of Medicine St Louis Missouri 63110-1032 —
Saint Louis University Academic Pavillion St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68198-2265 —
Reno Heart Institute Reno Nevada 89511 —
Winthrop University Hospital Mineola New York 11501 —
Mount Sinai New York New York 10029 —
Columbia University New York New York 10032 —
Stony Brook University Medical Center Stony Brook New York 11794 —
Duke Durham North Carolina 27710-4000 —
Lindner Clinical Trial Center/Christ Hospital Cincinnati Ohio 45219 —
Integris Baptist Office Oklahoma City Oklahoma 73112 —
The Oregon Clinic Pulmonary West Beaverton Oregon 97008 —
The Oregon Clinic Portland Oregon 97220-9442 —
Oregon Health And Science University Portland Oregon 97239-3011 —
University of Pennsylvania Philadelphia Pennsylvania 19104-5545 —
Allegheny General Hospital of Research Pittsburgh Pennsylvania 15212 —
Lankenau Medical Center Wynnewood Pennsylvania 19096 —
AnMed Health Anderson South Carolina 29621 —
UT Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine (BCM) - Baylor Heart Clinic Houston Texas 77030 —
Baylor Scott White - Plano Plano Texas 75093 —
San Antonio Methodist TX Transplant Physicians Group San Antonio Texas 78229-3771 —
The Robert Larner, M.D. College of Medicine at The University of Vermont Burlington Vermont 05405 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
Medical College Of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 231 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04273945, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04273945 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →